SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Agilon Health, Inc. – ‘8-K’ for 8/4/22

On:  Thursday, 8/4/22, at 4:22pm ET   ·   For:  8/4/22   ·   Accession #:  950170-22-14775   ·   File #:  1-40332

Previous ‘8-K’:  ‘8-K’ on / for 5/24/22   ·   Next:  ‘8-K’ on / for 8/10/22   ·   Latest:  ‘8-K’ on / for 2/27/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/04/22  Agilon Health, Inc.               8-K:2,9     8/04/22   11:1M                                     Donnelley … Solutions/FA

Current Report   —   Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     59K 
 2: EX-99.1     Miscellaneous Exhibit                               HTML    783K 
 6: R1          Document And Entity Information                     HTML     48K 
 9: XML         IDEA XML File -- Filing Summary                      XML     12K 
 7: XML         XBRL Instance -- agl-20220804_htm                    XML     16K 
 8: EXCEL       IDEA Workbook of Financial Reports                  XLSX      8K 
 4: EX-101.LAB  XBRL Labels -- agl-20220804_lab                      XML     42K 
 5: EX-101.PRE  XBRL Presentations -- agl-20220804_pre               XML     32K 
 3: EX-101.SCH  XBRL Schema -- agl-20220804                          XSD     11K 
10: JSON        XBRL Instance as JSON Data -- MetaLinks               11±    18K 
11: ZIP         XBRL Zipped Folder -- 0000950170-22-014775-xbrl      Zip     46K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX:   C:  C:  C: 
  8-K  
 i 0001831097 i false00018310972022-08-042022-08-04

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM  i 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  i August 04, 2022

 

 

 i agilon health, inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

 i Delaware

 i 001-40332

 i 37-1915147

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

 i 6210 E Hwy 290, Suite 450

 

 i Austin,  i Texas

 

 i 78723

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code:  i 562  i 256-3800

 

 i Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 i Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 i Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 i Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 i Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

 i Common stock, par value $0.01 per share

 

 i AGL

 

 i The New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company  i 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 


 

Item 2.02 Results of Operations and Financial Condition.

On August 4, 2022, agilon health, inc., a Delaware corporation, issued a press release setting forth its financial results for the three and six months ended June 30, 2022. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated by reference herein.

 

The information set forth in this Item 2.02 of this Current Report on Form 8-K and the related information in Exhibit 99.1 attached hereto is being furnished herewith, and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section and shall not be incorporated by reference in any filing with, the Securities and Exchange Commission under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference therein.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit

Number

 

 

Description

 

 

 

  99.1

 

Press Release dated August 4, 2022.

 

 

 

 104

 

 Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 


 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

agilon health, inc.

 

 

 

 

Date:

August 4, 2022

By:

/s/ TIMOTHY S. BENSLEY

 

 

 

Timothy S. Bensley
Chief Financial Officer

 

 



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed on / For Period end:8/4/22None on these Dates
6/30/22
 List all Filings 
Top
Filing Submission 0000950170-22-014775   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Mar. 28, 5:31:23.2pm ET